Lantheus Holdings (LNTH) Gains from Investment Securities (2020 - 2024)
Lantheus Holdings (LNTH) posted quarterly Gains from Investment Securities of -$1.3 million for Q4 2024, down 747.0% year-over-year from $200000.0 in Q1 2024, and down 1394.0% quarter-over-quarter from $100000.0 in Q2 2024.
Lantheus Holdings (LNTH) Gains from Investment Securities (2020 - 2024) Analysis & Trends
Lantheus Holdings (LNTH) has reported Gains from Investment Securities for 5 consecutive years, with -$1.3 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Gains from Investment Securities fell 747.0% year-over-year to -$1.3 million; the TTM figure through Dec 2024 stood at -$994000.0 (up 89.28% YoY), while the FY2024 annual figure was -$2.7 million, up 70.9% from the prior year.
- Gains from Investment Securities slipped to -$1.3 million in Q4 2024 per LNTH's latest filing, from $100000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $43.9 million in Q4 2021 and bottomed at -$7.6 million in Q2 2023.
- Historically, Gains from Investment Securities has averaged $5.9 million across 5 years, with a median of $250000.0 in 2021.
- Annual changes were most pronounced in 2022 — Gains from Investment Securities jumped 6033.33% — and 2024, when it sank 747.0%.
- Lantheus Holdings' Gains from Investment Securities stood at -$2.8 million in 2020, then surged by 1667.86% to $43.9 million in 2021, then plunged by 78.82% to $9.3 million in 2022, then sank by 97.85% to $200000.0 in 2023, then plunged by 747.0% to -$1.3 million in 2024.
- Business Quant data shows LNTH's Gains from Investment Securities at -$1.3 million in Q4 2024, $100000.0 in Q2 2024, and $200000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.29 Mn |
| Dec 31, 2024 | -1.29 Mn |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | -500,000.00 |
| Sep 30, 2023 | -500,000.00 |
| Jun 30, 2023 | -7.58 Mn |
| Jun 30, 2023 | -7.58 Mn |
| Mar 31, 2023 | -1.40 Mn |
| Mar 31, 2023 | -1.40 Mn |
| Dec 31, 2022 | 9.30 Mn |
| Dec 31, 2022 | 9.30 Mn |
| Sep 30, 2022 | -1.50 Mn |
| Sep 30, 2022 | -1.50 Mn |
| Jun 30, 2022 | 8.50 Mn |
| Jun 30, 2022 | 8.50 Mn |
| Mar 31, 2022 | 18.40 Mn |
| Mar 31, 2022 | 18.40 Mn |